Open AccessSelpercatinib (Retevmo)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.469
Subject(s) - contraindication , medicine , medullary thyroid cancer , thyroid cancer , cancer , disease , first line , medullary cavity , intensive care medicine , oncology , pathology , alternative medicine